These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 31486418)
21. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer. Dong L; Li Y; Xue D; Liu Y IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839 [TBL] [Abstract][Full Text] [Related]
22. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer. Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665 [TBL] [Abstract][Full Text] [Related]
23. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
24. Elevated expression of thyroid hormone receptor-interacting protein 13 drives tumorigenesis and affects clinical outcome. Dazhi W; Mengxi Z; Fufeng C; Meixing Y Biomark Med; 2017 Jan; 11(1):19-31. PubMed ID: 27827544 [TBL] [Abstract][Full Text] [Related]
25. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088 [TBL] [Abstract][Full Text] [Related]
26. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth. Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853 [TBL] [Abstract][Full Text] [Related]
27. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Tuo Z; Zhang J; Xue W Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110 [TBL] [Abstract][Full Text] [Related]
28. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis. Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732 [TBL] [Abstract][Full Text] [Related]
29. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder. Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277 [TBL] [Abstract][Full Text] [Related]
30. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer. Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755 [TBL] [Abstract][Full Text] [Related]
31. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma. Afaq F; Agarwal S; Bajpai P; Diffalha SA; Kim HG; Peter S; Khushman M; Chauhan SC; Mukherjee P; Varambally S; Manne U Neoplasia; 2024 Jan; 47():100951. PubMed ID: 38039923 [TBL] [Abstract][Full Text] [Related]
32. Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer. Wu D; Lin J; Zhu Y; Zhang H; Zhong Y Med Sci Monit; 2019 Jul; 25():5289-5298. PubMed ID: 31310599 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways. Lan J; Huang J; Tao X; Gao Y; Zhang L; Huang W; Luo J; Liu C; Deng Y; Liu L; Liu X J Cell Mol Med; 2022 May; 26(9):2673-2685. PubMed ID: 35322916 [TBL] [Abstract][Full Text] [Related]
34. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway. Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147 [TBL] [Abstract][Full Text] [Related]
35. TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling. Cai W; Ni W; Jin Y; Li Y Cancer Biomark; 2021; 30(2):237-248. PubMed ID: 33136091 [TBL] [Abstract][Full Text] [Related]
36. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells. Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157 [TBL] [Abstract][Full Text] [Related]
37. Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia. Zhou K; Zhang W; Zhang Q; Gui R; Zhao H; Chai X; Li Y; Wei X; Song Y Oncotarget; 2017 Apr; 8(15):25469-25481. PubMed ID: 28424416 [TBL] [Abstract][Full Text] [Related]
38. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer. Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349 [TBL] [Abstract][Full Text] [Related]
39. miR-19a promotes invasion and epithelial to mesenchymal transition of bladder cancer cells by targeting RhoB. Li Z; Li Y; Wang Y J BUON; 2019; 24(2):797-804. PubMed ID: 31128038 [TBL] [Abstract][Full Text] [Related]
40. SATB1 overexpression regulates the development and progression in bladder cancer through EMT. Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]